Company / Gross Margin
Eton Pharmaceuticals, Inc. Gross Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
66.6%
FY2025
5-year range
-1018.0% / 87.1%
FY2021-FY2025
Trend
-1.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 87.1% to 66.6% over the past 2 years.
Based on SEC 10-K filings.
66.6% in FY2025 with a 5-year CAGR of +13.8%.
Declined from 87.1% to 66.6% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +1084.5pp
- 5-Year Change
- +13.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 1.2% year-over-year.
- Peak gross margin was recorded in FY2019.
- Lowest gross margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 66.6% | -1.2% |
| FY2024 | 67.4% | -22.6% |
| FY2023 | 87.1% | +108.6% |
| FY2022 | -1018.0% | -2029.4% |
| FY2021 | 52.8% | +0.0% |
| FY2020 | 52.8% | -47.9% |
| FY2019 | 101.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026